NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
29.64
-0.91 (-2.98%)
At close: Jul 24, 2026, 4:00 PM EDT
30.09
+0.45 (1.52%)
After-hours: Jul 24, 2026, 7:58 PM EDT

NAMS Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Needham
Needham
Buy
Maintains
$48
BuyMaintains$48+61.94%Jul 24, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$48$52
BuyReiterates$48$52+75.44%Jul 24, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJul 24, 2026
BMO Capital
BMO Capital
Buy
Initiates
$32$58
BuyInitiates$32$58+95.68%Jul 20, 2026
RBC Capital
RBC Capital
Buy
Maintains
$47$51
BuyMaintains$47$51+72.06%Jun 30, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$60
BuyMaintains$60+102.43%May 12, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 8, 2026
Guggenheim
Guggenheim
Buy
Maintains
$45
BuyMaintains$45+51.82%May 8, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.